One Body, Many Stages: Why the Right Medication Dose at 30 Can Be the Wrong One at 70

A prescription is not a permanent, universal prescription. The drug that effectively managed a condition in early adulthood may behave very differently in the same person at 65 — not because the medication changed, but because the body processing it did. Across a human lifespan, the organs responsible for absorbing, distributing, metabolizing, and eliminating drugs undergo gradual but significant transformation. Pediatric patients are not simply small adults. Older adults are not simply older versions of their middle-aged selves. Each life stage carries its own pharmacological profile, and that profile has real consequences for medication safety and effectiveness.

The Foundation: How the Body Handles Drugs

Before examining how age alters medication response, it helps to understand the four stages every drug passes through inside the body — collectively referred to by the acronym ADME: Absorption, Distribution, Metabolism, and Excretion.

• Absorption describes how a drug moves from the point of administration into the bloodstream.
• Distribution refers to how the drug spreads through bodily tissues and fluids.
• Metabolism is the process by which the liver and other organs chemically transform the drug.
• Excretion describes how the drug and its byproducts are eliminated, primarily through the kidneys.

Each of these processes is influenced by body composition, organ function, and hormonal environment — all of which shift meaningfully across a lifetime.

Infants and Young Children: A Fundamentally Different Pharmacology

Pediatric dosing is among the most complex areas of clinical pharmacology, and for good reason. Infants are not simply small adults. Their organ systems are still developing, and that immaturity affects every stage of drug processing.

Newborns have reduced stomach acid production, which affects the absorption of oral medications. Their kidneys are not yet fully functional, meaning drugs that are renally excreted can accumulate to dangerous levels if dosed using adult standards. The blood-brain barrier — which normally limits what substances can enter the brain — is more permeable in early life, making infants particularly vulnerable to central nervous system side effects from certain drugs.

Liver enzyme activity, which governs metabolism, also matures gradually and at different rates for different enzymes. Some metabolic pathways are not fully active until several years after birth. This is why pediatric doses are typically calculated per kilogram of body weight rather than given as flat amounts, and why certain medications are contraindicated entirely in children below specific age thresholds.

Parents should never adjust a child's medication dose based on adult instructions on a package, even for over-the-counter products. Pediatric formulations exist for important physiological reasons.

Adolescence and Young Adulthood: Peak Metabolic Efficiency

By late adolescence, most of the body's drug-processing systems have reached their functional peak. Liver enzyme activity, kidney filtration rates, and body composition stabilize into patterns that most standard adult drug dosing is designed around. The clinical trials that established approved doses for the majority of medications were conducted predominantly on adults in this age range — a fact that has implications for every other population group.

That said, adolescence introduces its own pharmacological considerations. Hormonal fluctuations during puberty can affect how certain psychiatric medications are tolerated. Body weight and composition vary considerably during growth spurts, making weight-based dosing relevant for some drug classes. Young women beginning hormonal contraceptives during this period should also be aware that certain medications — including some antibiotics, antiepileptics, and antifungals — can interfere with contraceptive efficacy through enzyme interactions.

Pregnancy: A Temporary but Profound Physiological Shift

Pregnancy creates a cascade of changes that alter nearly every aspect of drug pharmacology. Blood volume increases by roughly 40 to 50 percent, which dilutes drug concentrations in the bloodstream. Kidney filtration rates increase, accelerating the excretion of many medications. Gastrointestinal motility slows, which can affect absorption timing. Liver enzyme activity changes in ways that speed up the metabolism of some drugs and slow others.

The practical consequence is that some medications require higher doses during pregnancy to achieve the same therapeutic effect — a counterintuitive reality for patients and sometimes for providers who are less experienced in obstetric pharmacology. Seizure medications, for instance, may need dose adjustments during pregnancy because accelerated clearance can drop blood levels below the therapeutic threshold, increasing seizure risk at exactly the time seizure control is most critical.

At the same time, the developing fetus is exposed to many substances that cross the placenta. The US Food and Drug Administration previously categorized drugs by pregnancy risk (Categories A through X) and has since shifted to more nuanced labeling that describes what is known about fetal risk. Patients who are pregnant or planning to become pregnant should review all current medications with their obstetrician and primary care provider before conception if possible.

Perimenopause and Menopause: Hormonal Recalibration

The hormonal transition of perimenopause and menopause affects medication response in ways that are often underappreciated. Estrogen plays a role in the activity of certain liver enzymes, and declining estrogen levels can alter the metabolism of drugs that rely on those pathways. Women may notice that medications they have taken for years — antidepressants, migraine treatments, thyroid hormones — seem to work differently during this transition.

Bone density loss associated with menopause also brings many women into contact with bisphosphonate medications such as alendronate. These drugs have strict administration requirements (taken with a full glass of water, remaining upright for 30 minutes afterward) that reflect their unusual absorption characteristics and potential for esophageal irritation — a side effect profile that demands careful patient education.

Older Adults: When Standard Doses Become Risky

The most clinically significant changes in drug response occur in older adulthood, typically defined as 65 and above for pharmacological purposes. Several concurrent physiological shifts combine to alter how medications behave:

Kidney function declines with age. Renal filtration rates drop gradually but predictably, meaning drugs excreted through the kidneys are eliminated more slowly. For medications with a narrow therapeutic window — where the effective dose and the toxic dose are close together — this reduced clearance can cause dangerous accumulation. Common examples include digoxin, certain antibiotics, metformin, and gabapentin.

Liver size and blood flow decrease. The liver's capacity to metabolize drugs diminishes, affecting the first-pass metabolism of many oral medications and slowing the breakdown of others.

Body composition shifts. Older adults typically have less lean muscle mass and a higher proportion of body fat relative to their younger selves. Fat-soluble drugs distribute more widely and linger longer. Water-soluble drugs achieve higher concentrations in the bloodstream because there is proportionally less body water to dilute them.

Protein binding changes. Many drugs travel through the bloodstream bound to albumin, a blood protein. Older adults often have lower albumin levels, which means more of certain drugs remain in their free, active form — increasing both their effect and their potential for side effects.

The Beers Criteria, maintained by the American Geriatrics Society, is a widely referenced list of medications considered potentially inappropriate for older adults. It includes some antihistamines, certain benzodiazepines, and specific muscle relaxants — drugs that are generally manageable in younger patients but carry elevated risks of falls, confusion, and over-sedation in older individuals.

A Lifelong Conversation with Your Care Team

The most important takeaway from understanding lifespan pharmacology is that medication reviews should be an ongoing process, not a one-time event. A drug regimen that was appropriate at one life stage deserves re-examination as circumstances change — whether that means a new pregnancy, the onset of menopause, a significant birthday, or the addition of a new chronic condition.

Patients are encouraged to:

• Request a medication review from their primary care provider or pharmacist at any major life transition.
• Report changes in how medications feel, including new side effects or reduced effectiveness, which may signal that the body has changed in ways that affect the drug.
• Never adjust doses independently based on the assumption that more or less is needed. Dose changes should be guided by clinical assessment.
• Inform every provider of all medications being taken, including over-the-counter drugs and supplements, since interactions compound across life stages.

Medications are calibrated for bodies — and bodies are always changing. Staying informed about how those changes affect your prescriptions is one of the most proactive steps you can take for your long-term health.